Search research articles
Contact Us
Filters
Showing results (271-280 of 336) with videos related to
Page
of 34
Sort By:
Journal of the National Cancer Institute
|
December 26, 2022
Cognitive change in breast cancer patients up to 2 years after diagnosis
Marie Lange, Sophie Lefevre Arbogast, Isabelle Hardy-Léger, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 21, 2013
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis
Benoit Beuselinck, Alexandra Karadimou, Diether Lambrechts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2014
A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors
Eric Angevin, Josep Tabernero, Elena Elez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2020
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
Benoit You, Patrick Robelin, Michel Tod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)
Alexandra Drakaki, Thomas Powles, Aristotelis Bamias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on <i>FGFR1</i>/<i>3</i> mRNA Expression
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, et al.
Gynecologic Oncology
|
July 23, 2021
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database
Alexandre De Nonneville, Christophe Zemmour, Sophie Frank, et al.
Nature Communications
|
January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
JCO Precision Oncology
|
January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial
Félix Blanc-Durand, Benoit You, Yahia Adnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium
Nicole Concin, Ioana Braicu, Pierre Combe, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 336) with videos related to
Sort By:
Page
of 34
Journal of the National Cancer Institute
|
December 26, 2022
Cognitive change in breast cancer patients up to 2 years after diagnosis
Marie Lange, Sophie Lefevre Arbogast, Isabelle Hardy-Léger, et al.
Acta Oncologica (Stockholm, Sweden)
|
February 21, 2013
VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis
Benoit Beuselinck, Alexandra Karadimou, Diether Lambrechts, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2014
A phase I/II, multiple-dose, dose-escalation study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with advanced solid tumors
Eric Angevin, Josep Tabernero, Elena Elez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2020
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
Benoit You, Patrick Robelin, Michel Tod, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 31, 2023
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma)
Alexandra Drakaki, Thomas Powles, Aristotelis Bamias, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2022
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on <i>FGFR1</i>/<i>3</i> mRNA Expression
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, et al.
Gynecologic Oncology
|
July 23, 2021
Clinicopathological characterization of a real-world multicenter cohort of endometrioid ovarian carcinoma: Analysis of the French national ESME-Unicancer database
Alexandre De Nonneville, Christophe Zemmour, Sophie Frank, et al.
Nature Communications
|
January 6, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma, et al.
JCO Precision Oncology
|
January 14, 2026
Early Clinical and Molecular Biomarkers in Patients With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: CHIVA Phase II GINECO Trial
Félix Blanc-Durand, Benoit You, Yahia Adnani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium
Nicole Concin, Ioana Braicu, Pierre Combe, et al.
Page
of 34